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a significant increase in serum bicarbonate (21.5  8 3.4 vs. 
28.6  8 1.6 mmol/l; p = 0.018) and blood pH (7.41 vs. 7.46; p = 
0.041). The FSR of muscle protein and the FSR of albumin did 
not change significantly (muscle protein: 2.1  8 0.2 vs. 2.0  8 
0.5% per day, p = 0.39; albumin: 8.3  8 2.2 vs. 8.6  8 2.5% per 
day, p = 0.31). Plasma concentrations of insulin-like growth 
factor 1 decreased significantly (33.4  8 21.3 vs. 25.4  8 12.3 
nmol/l; p = 0.028), whereas thyroid-stimulating hormone, 
free thyroxin and free triiodothyronine did not change sig-
nificantly and nutritional parameters showed no improve-
ment.  Conclusion: In contrast to other findings, raising the 
blood pH of dialysis patients was not associated with a posi-
tive effect on albumin and muscle protein synthesis, or nu-
tritional and endocrinal parameters. 
 Copyright © 2009 S. Karger AG, Basel 
 Introduction 
 Many patients with chronic kidney disease (CKD) dis-
play body protein wasting, and often remain wasted de-
spite dialysis  [1, 2] . Depending on the method of assess-
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 Abstract 
 Background: Although the mechanism of muscle wasting in 
end-stage renal disease is not fully understood, there is in-
creasing evidence that acidosis induces muscle protein deg-
radation and could therefore contribute to the loss of muscle 
protein stores of patients on hemodialysis, a prototypical 
state of chronic metabolic acidosis (CMA). Because body 
protein mass is controlled by the balance between synthesis 
and degradation, protein loss can occur as result of either 
increased breakdown, impaired synthesis, or both. Correc-
tion of acidosis may therefore help to maintain muscle mass 
and improve the health of patients with CMA. We evaluated 
whether alkalizing patients on hemodialysis might have a 
positive effect on protein synthesis and on nutritional pa-
rameters.  Methods: Eight chronic hemodialysis patients 
were treated daily with oral sodium bicarbonate (NaHCO 3 ) 
supplementation for 10–14 days, yielding a pre-dialytic plas-
ma bicarbonate concentration of 28.6  8 1.6 mmol/l. The frac-
tional synthesis rates (FSR) of muscle protein and albumin 
were obtained by the L-[ 2 H 5 ring]phenylalanine flooding 
technique.  Results: Oral NaHCO 3  supplementation induced 
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ment of catabolic factors, wasting has been observed in 
up to 70% of patients on hemodialysis (HD) and in 18–
56% of patients undergoing continuous ambulatory peri-
toneal dialysis (CAPD)  [3] . The assessment was based on 
a combination of clinical, biophysical and biochemical 
parameters. Serum albumin concentrations  ! 40 g/I are 
associated with higher mortality rates  than concentra-
tions  1 40 g/I  [3, 4] .  Prealbumin may also predict mortal-
ity in both CAPD and HD patients  [5–7] .
 Although low serum proteins and muscle wasting in 
HD patients have often been attributed to malnutrition 
(i.e. an inadequate protein and energy intake), recent ev-
idence suggests that malnutrition is not the principal 
cause. Other factors, such as inflammation and/or resis-
tance to anabolic hormones, may also interfere with con-
trol of the protein balance  [2] . In addition, several studies 
suggest that metabolic acidosis represents a major stimu-
lus for protein degradation and muscle wasting in CKD 
patients. Metabolic acidosis resulting from the impaired 
excretion of non-volatile organic acids and reduced renal 
synthesis of bicarbonate accompanies both acute and 
chronic renal failure  [8, 9] . Despite HD with a high bicar-
bonate buffer of 35 mmol/l, a significant number of pa-
tients remain acidotic  [10] .
 Attempts to reduce protein degradation and/or in-
crease protein synthesis, and thus improve nitrogen re-
tention, are important for the development of strategies 
to counteract muscle wasting and to improve protein ho-
meostasis and survival in catabolic diseases (e.g. sepsis, 
renal and liver failure, HIV, cancer, anorexia and starva-
tion). However, the mechanisms of muscle protein wast-
ing in different catabolic processes are complex and poor-
ly understood.
 The important role of metabolic acidosis in the devel-
opment of protein degradation is indicated by the fact that 
correction of acidosis induces normal growth in children 
with renal tubular acidosis  [11] and leads to downregula-
tion of ubiquitin mRNA in CAPD patients. Activation of 
the intracellular ATP-dependant ubiquitin proteasome 
pathway is one of the most important mechanisms for 
protein degradation  [2, 9, 12, 13] . Moreover, there have 
been studies examining the impact of metabolic acidosis 
in human volunteers given ammonium chloride orally. 
The study of Ballmer et al.  [14] confirmed that induced 
metabolic acidosis causes a negative nitrogen balance and 
a significant decrease in serum albumin synthesis. Fur-
thermore, Reaich et al.  [15] found a significant increase in 
protein breakdown and amino acid oxidation after the in-
gestion of NH 4 CI for 5 days, findings confirmed by Strau-
mann et al.  [16] but not by Nair et al.  [17] . In addition, a 
depression in muscle protein synthesis was observed after 
2 days of metabolic acidosis in humans  [18] and after 1 day 
in rats  [19, 20] . However, prior studies had failed to detect 
a response in protein synthesis  [21, 22] .
 Body protein homeostasis depends on the balance be-
tween synthesis and degradation. Because proteins are 
continually degraded and synthesized, protein loss can 
occur as result of either increasing the breakdown, de-
creasing the synthesis, or both.
 The inhibition of protein synthesis by acidosis poses 
the logical question of whether alkalosis reverses this ef-
fect and stimulates protein synthesis.
 More recent studies have come to the conclusion that 
muscle protein synthesis is inhibited by acidosis and may 
also be stimulated by alkalosis  [23] . Thus, correction of 
acidosis in non-dialysed patients with CKD improves the 
nitrogen balance  [24, 25] . In a study with 18 non-dialysed 
patients 6 months after oral supplementation with sodi-
um bicarbonate (NaHCO 3 ), Verove et al.  [26] found an 
increase in serum albumin and prealbumin concentra-
tions and a decrease in the protein catabolic rate. Patients 
on HD after 3 months of correction of metabolic acidosis 
showed an increase in their albumin concentrations and 
an improvement in protein catabolic rates  [27] . However, 
the study of Brady and Hasbargen  [4] did not show any 
benefit of raising the pre-dialysis bicarbonate from 17 to 
20 mmol/l. More direct evidence for a role of alkalosis 
was observed in a study of intensive care patients, in 
whom hyperventilation, involving respiratory alkalosis, 
stimulated muscle protein synthesis  [28] . Increasing bi-
carbonate concentration has also been shown to correct 
insulin-like growth factor 1 (IGF-1) levels, improve 
growth   hormone sensitivity and normalize free triiodo-
thyronine (T 3 )  [29] .
 The aim of the study is therefore to investigate wheth-
er increasing the serum pH and bicarbonate concentra-
tion in patients with chronic metabolic acidosis (CMA) 
would reverse IGF-1 and thyroid alterations, improve cat-
abolic status and enhance protein synthesis.
 Methods 
 Subjects 
 Eight uremic patients (7 males and 1 female, mean age: 58  8 15 
years, serum urea: 20.5  8 4.9 mmol/l; serum creatinine: 869.1  8 
236.7   mol/l), who had been on regular HD thrice weekly for at 
least 1 year, were recruited for the study. The main demographic 
and renal disease characteristics are shown in  table 1 . Inclusion 
criteria were as follows: mean pre-dialysis serum bicarbonate  ! 18 
mmol/l on 1 measurement during the last 3 months and a clini-
cally stable condition. Patients on oral supplementation with 
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NaHCO 3 , with cancer, systemic inflammatory disease, chronic 
liver disease or severe wasting (BMI  ! 15, body weight loss in 3 
months  1 10%) were excluded. The study was approved by the lo-
cal ethics committee of the Kantonsspital Winterthur, Switzer-
land. All patients gave written informed consent.
 Preliminary Study 
 The pre-study was performed with the aim of determining the 
dose of NaHCO 3 required to increase the blood HCO 3 concentra-
tion above 25 mmol/l. Six of the patients of the main study were 
placed on oral supplementation with NaHCO 3 for 2 weeks. Each 
tablet contained 7.7 mEq of HCO 3 , and each patient received 1 
mEq/kg dry weight/day of bicarbonate, rounded to the nearest 
tablet and divided into 3 doses. To optimize the over-correction 
procedure, the required dose of NaHCO 3 was adjusted according 
to the plasma HCO 3 concentration measured before each dialysis 
session.
 Measurement of Muscle Protein Synthesis Rate 
 Protein synthesis rates were measured with the flooding 
method, as described previously  [18] . Before the dialysis session 
and after an overnight fast, 0.043 g/kg body [ 2 H 5 ring]phenylala-
nine (Tracer Technologies, Sommerville, Mass., USA), with an 
isotopic enrichment of 7.5 atom% in the first measurement (visit 
A) and 15 atom% in the second measurement (visit B), was intra-
venously infused in the arm opposite the arteriovenous fistula 
(AV fistula) over 10 min.
 [ 2 H 5 ring]Phenylalanine was mixed with unlabeled  L -phenyl-
alanine (Merck, Darmstadt, Germany) in 0.45% NaCl. The sterile 
solution was prepared by the hospital pharmacy. Blood samples 
were drawn from the AV fistula at 0, 5, 10, 15, 20, 30, 50 and 90 
min. The total blood loss per measurement was about 150 ml. At 
90 min, a percutaneous muscle biopsy of about 50 mg was taken 
from the vastus lateralis under local anaesthesia by means of a 
biopsy gun (first measurement, visit A). For the second measure-
ment of protein synthesis (visit B), an additional muscle biopsy 
was taken at time point zero, for determining the baseline enrich-
ment. Plasma and muscle samples were immediately frozen in 
liquid N 2 and stored at –70 ° C until further analysis.
 Measurement of Albumin Synthesis Rate 
 After thawing the plasma, albumin was isolated by ethanol 
extraction from trichloroacetic acid-precipitated plasma pro-
teins, as described previously  [30–34] . In every subject, the purity 
of the albumin isolates was checked by sodium dodecylsulphate 
gel electrophoresis and compared with a human albumin stan-
dard (Sigma, Poole, UK). All isolates presented as a single band 
corresponding to human albumin. After repeat washes with 2% 
perchloric acid, the albumin was hydrolyzed in 6 mol HCl for
24 h at 105 ° C. The hydrolysates were purified by washing with 
distilled water and then dried in a stream of N 2 .
 Patients were instructed to maintain their usual diet and ac-
tivities throughout the study. Medication and dialysis prescrip-
tions were not changed. All patients were dialysed 3 times weekly 
at a dialysate bicarbonate concentration of 30 mmol/l.
 Calculation of Protein Synthesis Rates 
 Muscle protein synthesis was calculated as the fractional syn-
thesis rate (FSR) expressed as percent per day. FSR was calculated 
by dividing the increase in  L -[ 2 H 5 ring]phenylalanine enrichment 
in muscle protein (P 2 – P 1 ) between 0 and 90 min by the area (A) 
under the curve of free phenylalanine (precursor) enrichment  [14, 
18, 30] .
 FSR = (P 2 – P 1 )  ! 100/A
 The FSR of albumin was also calculated as described above. 
FSR of albumin results from the increase in phenylalanine enrich-
ment in albumin between 50 (P 1 ) and 90 (P 2 ) min by the corre-
sponding area under the curve of free phenylalanine enrich-
ment.
 Body Composition Analysis 
 Body impedance analysis was performed between 07.00 and 
07.30 h (after measurement of protein synthesis and before the 
HD session). Resistance and reactance were used to calculate 
body water, fat, and fat-free mass.
 Biochemical Blood Parameters 
 Albumin, prealbumin and transferrin concentrations were 
measured before the measurement of protein synthesis by brom-
cresol purple. Plasma acid-base analysis was performed in AV fis-
tula blood samples (Radiometer ABL system 652 Blood Gas Ana-
lyzer, Radiometer, Copenhagen, Denmark).
 Plasma concentrations of total IGF-1, free thyroxin (fT 4 ), free 
triiodothyronine (fT 3 ) and thyroid-stimulating hormone (TSH) 
were measured by standard radioimmunoassay methods  [14, 
18] .
 Statistics 
 Statistical comparisons were performed by Student’s paired t 
test. Values of p  ! 0.05 were considered significant.
 Results 
 Eight patients completed the study (7 men, 1 woman). 
One patient (No. 4) failed to show an increase in serum 
bicarbonate after oral NaHCO 3 supplementation, due to 
Table 1. Patients’ characteristics at time of entry into study
Sub-
ject
No.
Sex Age
years
Weight
kg
pH HCO3 
mmol/l
Cause of chronic
renal failure
1 M 29 84.5 7.37 18.4 hypertension
2 M 49 77.5 7.41 16.3 unknown
3 M 51 51.5 7.45 24.4 glomerulonephritis
4 M 69 74.0 7.39 21.5 diabetes mellitus,
hypertension
5 M 59 75.5 7.44 23.7 diabetes mellitus,
hypertension
6 F 61 47.0 7.42 25.1 unknown
7 M 79 71.5 7.42 19.4 obstructive uropathy
8 M 66 72.5 7.40 23.1 glomerulonephritis
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poor adherence to the protocol, and was therefore exclud-
ed from the analysis. The average patient age was 58 years 
old (range 29–78 years). Six patients were of normal body 
composition, with an average BMI of 24.8  8 3.25, and 1 
patient (No. 6) had a BMI of 17. Oral supplementation 
with NaHCO 3 induced increases in plasma bicarbonate, 
pH and sodium. The bicarbonate of arterialized blood 
increased from 21.5  8 3.4 to 28.6  8 1.6 mmol/l (p = 
0.018), pH from 7.41 to 7.46 (p = 0.041) and sodium from 
136.3  8 2.4 to 138.4  8 1.7 mmol/l (p = 0.026). The body 
weight increased from 70.8  8  15 to 71.8  8  15.2 kg (p = 
0.034) ( table 2 ).
 The FSR of muscle protein did not change significant-
ly after treatment with NaHCO 3 (2.1  8 0.2 vs. 2.0  8 0.5% 
per day; p = 0.39), neither did the FSR of plasma albumin 
(8.3  8 2.2 vs. 8.6  8 2.5% per day; p = 0.31) ( table 3 ).
 Serum concentrations of TSH, fT 4 and fT 3 also did not 
change significantly. Circulating plasma concentrations 
of IGF-1 before dialysis were in the normal range, but de-
creased significantly after bicarbonate supplementation 
(33.4  8 21.3 vs. 25.4  8 12.3 nmol/l; p = 0.028) ( table 4 ).
 The treatment with oral NaHCO 3 did not change plas-
ma concentrations of the commonly used biochemical 
parameters of nutritional status: prealbumin (393  8 64.5 
vs. 377.6  8 46.9 mg/l; p = 0.17), plasma protein (69.7  8 
4.0 vs. 69.3  8 2.6 g/l; p = 0.49), albumin (37.9  8 4.2 vs. 
38.3  8 2.8 g/l; p = 0.73) and transferrin (21.3  8 4.6 vs. 
22.1  8 2.6   mol/l; p = 0.46) ( table 5 ).
 Body impedance analysis could be completed in 6 sub-
jects (patient No. 1 missed the measurement at visit A). 
The extracellular mass/body cellular mass index did not 
change significantly (0.85 vs. 0.89 kg; p = 0.9), due to a 
decrease in body cellular mass (0.7 kg) and an increase in 
extracellular mass (1.6 kg). Lean body mass increased, 
but not significantly, by 0.9 kg (p = 0.34). The total body 
water increased minimally (0.6 l), and phase angle, vol-
ume overflow and sodium did not change significantly 
(pre-dialytic weight by +1 kg, and sodium by +2.1 mmol/
l after NaHCO 3  supplementation;  table 2 ). The extracel-
lular water decreased (19.1  8 4.6 vs. 18.0  8 3.6 l). Neither 
dialysis prescription nor antihypertensive therapy need-
ed adjustment for the sodium load.
Table 2. Blood pH, bicarbonate, sodium, blood urea nitrogen and creatinine before (A) and after (B) NaHCO3  supplementation
Subject
No.
Weight, kg pH HCO3, mmol/l Sodium, mmol/l BUN, mmol/l Creatinine, mol/l
A B A B A B A B A B A B
1 88.9 91.3 7.37 7.50 18.4 28 134 137 25.8 20.7 1,253 1,069.7
2 82 82.3 7.41 7.44 16.3 27 135 140 25.8 23.5 999.6 970.4
3 53.3 53.7 7.45 7.54 24.4 29.2 141 141 21.0 19.8 706 664.4
5 77.8 79.3 7.44 7.41 23.7 29.3 137 138 20.0 20.9 988.4 946.2
6 47.7 49.2 7.42 7.45 25.1 28.9 134 136 13.6 13.0 530 486.1
7 72.4 73 7.42 7.49 19.4 26.6 136 138 22.7 17.2 743.1 678.9
8 73.8 73.5 7.40 7.45 23.1 31.2 137 139 14.4 17.0 863.6 832.6
Means 
8 SE
70.8
815.0
71.8
815.2*
7.41 7.46* 21.5
83.4
28.6
81.6*
136.3
82.4
138.4
81.7* 
20.5
84.9
18.8
83.4
869.1
8236.7
806.9
8206.3*
BUN = Blood urea nitrogen. * p < 0.05.
Table 3. FSR of albumin and muscle protein before (A) and after 
(B) NaHCO3  supplementation
Sub-
ject
No.
Albumin FSR
% per day
Muscle protein FSR
% per day
A B A B
1 8.15 9.62 2.40 2.37
2 7.05 6.92 2.28 1.83
3 8.90 5.94 1.90 2.2
5 11.90 12.97 2.07 1.18
6 9.94 10.42 2.10 2.59
7 5.55 7.09 2.48 2.16
8 6.6 7.47 1.85 1.82
Means 8 SE 8.382.2 8.682.5 2.180.2 2.080.5
          p = 0.31         p = 0.39
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 Discussion 
 In this study, we investigated whether increasing the 
plasma bicarbonate concentration in patients on HD 
stimulated protein synthesis, improved nutritional status 
and reversed IGF-1 and thyroid derangements. Eight pa-
tients were placed on oral supplementation with NaHCO 3 
for 2 weeks. At the end of the 2 weeks, measurements of 
protein synthesis and relevant hormones were made. The 
results showed that 10–14 days of oral NaHCO 3 supple-
mentation did not affect the rates of synthesis of muscle 
protein and albumin, and that neither body protein status 
nor thyroid hormone status were altered. However, IGF-1 
plasma concentrations decreased significantly.
 There is increasing evidence that acidosis influences 
protein metabolism, not only by enhancing protein deg-
radation, but also by inhibiting protein synthesis  [35] . 
Several studies have demonstrated the substantial influ-
ence of   pH on whole body protein turnover and muscle 
protein degradation  [14–16, 36, 37] , but only a few studies 
have investigated the impact of pH on muscle protein 
synthesis in vivo. Garibotto et al.  [21] showed, using the 
arterio-venous difference technique and a constant infu-
sion of  L -[ 3 H]phenylalanine, that CKD patients had sig-
nificantly higher rates of both synthesis and degradation 
of muscle protein. However, the patients with CDK in 
that study had a mean bicarbonate concentration of 20 
mmol/l  [21] , and were therefore more comparable to sub-
jects without severe acidosis  [38] .
 In another study with humans, Kleger et al.  [18] mea-
sured muscle protein synthesis in healthy volunteers after 
induction of acute metabolic acidosis with NH 4 CI. The 
results showed that protein synthesis was depressed by 2 
days of metabolic acidosis.
 The more recent data of Caso et al.  [38] in adult rats 
suggest that the suppressive effect of metabolic acidosis 
Table 4. Plasma concentrations of fT3, fT4, TSH and IGF-1 before (A) and after (B) NaHCO3  supplementation
Subject
No.
fT3, nmol/l fT4, pmol/l TSH, mU/l IGF-1, nmol/l
A B A B A B A B
1 1.5 1.5 9.3 10.4 0.7 0.8 76 46
2 1.7 1.9 10.2 12 0.6 0.7 40 32
3 1.6 1.7 10.5 10.4 1.1 1.0 12 13
5 1.7 1.7 10.8 11.9 1.0 1.1 20 17
6 2.1 2 10 10.7 1.3 1.2 36 32
7 1.6 1.8 10.4 13 1.8 2.7 19 12
8 1.9 1.9 12.2 12 1.0 1.8 31 26
Means 8 SE 1.780.2 1.880.2 10.580.9 11.581.0 1.180.4 1.380.7 33.4821.3 25.4812.3
          p < 0.05           p < 0.05
Table 5. Biochemical parameters  before (A) and after (B) NaHCO3  supplementation
Subject
No.
Albumin, g/l Prealbumin, g/l Transferrin, mol/l Protein, g/l
A B A B A B A B
1 45.3 41.1 477 421 28 25 77.1 74.5
2 34.9 36.8 429 408 23 23 65.9 65.8
3 35.5 40.5 328 372 18 20 68.6 72.5
5 41.7 41.5 377 377 26 26 72.7 72.5
6 38.2 38 468 422 20 21 67.7 64.7
7 35.7 34.4 338 289 19 19 69.6 68.2
8 33.8 35.6 334 354 15 21 66.4 66.8
Means 8 SE 37.984.2 38.382.8 393.0864.5 377.6846.9 21.384.6 22.182.6 69.784.0 69.382.6
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on protein synthesis is mainly specific to skeletal muscle, 
and does not affect visceral tissues. However, studies on 
human volunteers have shown that serum albumin syn-
thesis is also depressed in metabolic acidosis  [14] . In oth-
er studies, correction of metabolic acidosis was shown to 
normalize growth in children with renal tubular acidosis 
 [11] and improve nitrogen balance in CKD  [25] .
 The benefit of bicarbonate supplementation in pa-
tients with metabolic acidosis has been known since 1931 
 [39] . However, dialysis with a high-normal bicarbonate 
solution is not sufficient to maintain a normal serum bi-
carbonate concentration over the complete inter-dialytic 
period, despite high post-dialysis blood pH  [40] . After 
correction of metabolic acidosis with oral bicarbonate 
supplementation, a decrease in protein degradation was 
observed by Reaich et al.  [25] and confirmed by Graham 
et al.  [41] . This evidence suggests that over-correction of 
acidosis might improve body protein status of patients on 
hemodialysis. However, when patients were exposed to 
different levels of bicarbonate, catabolic parameters, such 
as serum albumin and skin folds thickness, improved in 
some  [27, 42] but not in all studies  [4, 43, 44] .
 A recent study by Bossola et al.  [45] failed to show an 
effect on nutritional status of HD patients after long-term 
bicarbonate supplementation at the dose of 1 g thrice 
 daily.
 The present study did not show, as expected, a signifi-
cant improvement in total protein and albumin, but also 
prealbumin and transferrin plasma concentrations did 
not change. Moreover, no significant changes were re-
corded in the FSR of albumin and muscle protein, in 
agreement with the data of Reaich et al.  [25] and Graham 
et al.  [41] with 4 weeks on bicarbonate. However, in the 
study of Vosswinkel et al.  [28] , involving intensive-care 
patients, the same increase in pH (from 7.4 to 7.5) as in 
the present study induced a significant increase in muscle 
protein synthesis. The notable difference is that the previ-
ous study induced changes in pH by respiratory means, 
whereas the present study induced metabolic alkalosis. In 
animal studies, however, respiratory acidosis and meta-
bolic acidosis result in very similar depressions in muscle 
protein synthesis  [19, 20, 46] . It is not clear, therefore, 
whether the failure to demonstrate an improvement in 
protein synthesis in the present study may be related to 
the method of over-correction of acidosis or to other fac-
tors. A potential explanation of this lack of effect of alka-
linization may be the selection of the subjects; lean body 
mass, albumin and prealbumin of our patients did not 
reflect the abnormalities generally attributed to wasted 
patients. Another consideration is the lack of acidosis at 
the beginning of the study, although at the time of re-
cruitment the patients had had lower plasma bicarbonate, 
as required in the inclusion criteria.
 Putative hormonal mechanisms involved in the acido-
sis-induced downregulation of albumin synthesis were 
also investigated. Growth hormone, IGF-1, insulin and 
thyroid hormones are, together with cortisol, the most 
important hormones regulating protein synthesis and 
degradation  [14, 18] . Uremic patients often show labora-
tory findings suggestive of hypothyroidism, such as a low 
concentration of peripheral hormones and a blunted TSH 
response to thyrotropin-releasing hormone  [18, 29] . The 
most evident abnormality is the reduction in fT 3 , due to 
the decreased conversion of T 4 to T 3 by inhibition of 5  -
deiodinase  [47, 48] . Observations in healthy subjects after 
induction of metabolic acidosis indicated a mechanism at 
the level of the thyroid rather than a central inhibitory 
effect  [49] . After correction of CMA or successful renal 
transplantation, the thyroid function improved progres-
sively, with the circulating hormones reaching normal 
concentrations  [29, 50] . The present findings (low T 3 , low 
T 4 and low but still normal TSH levels) are consistent with 
thyroid dysfunction, which has been observed in CMA. 
However, the study failed to confirm a significant im-
provement after oral NaHCO 3 supplementation. A pos-
sible explanation for this failure is the short intervention 
period compared to other studies, i.e. after renal trans-
plantation, thyroid hormones reach normal concentra-
tions only after 8 days to 1 month  [50] .
 In human volunteers, IGF-1 inhibits protein degrada-
tion and stimulates protein synthesis  [51, 52] . Experimen-
tal studies with healthy humans showed that induced 
chronic but not acute metabolic acidosis reduced plasma 
IGF-1 concentrations due to peripheral insensitivity to 
growth hormone  [14, 18, 29] . In contrast, non-malnour-
ished patients on HD have serum IGF-1 concentrations 
that are similar or higher compared to subjects with nor-
mal renal function  [53–57] . However, intracellular IGF-1 
in the muscle has been shown to be markedly reduced 
 [57] . Recent observations have shown that correction of 
acidosis by oral citrate administration partially corrected 
the IGF-1 plasma concentrations and reversed growth 
hormone insensitivity  [29] .
 In the present patients, the pre-dialysis high IGF-1 
concentrations decreased to 70% after 10 days on oral 
NaHCO 3 supplementation. This suggests that over-cor-
rection may have an adverse effect on IGF-1 and that a 
mechanism other than acidosis must be responsible for 
reduction of circulating IGF-1 levels.
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 There are several limitations to our study. First, the 
number of patients was very low and significant changes 
might have been missed. Also, the observation period 
and supplementation were rather short, so that we may 
have missed a profound effect. However, depressions in 
muscle protein synthesis were already observed after 2 
days of induced metabolic acidosis in humans  [3] and af-
ter 1 day in rats  [4, 5] in previous studies.
 A further limitation may be the good quality of dialy-
sis in our patients. Many patients fulfilling the inclusion 
criterion of a pre-dialysis serum bicarbonate  ! 18 mmol/l 
within the last 3 months, showed a normal blood pH at 
the start of the study. It is therefore quite possible that the 
expected effect on albumin and muscle protein synthesis 
might only occur when the pH is below 7.4. Although the 
patients were instructed to maintain their usual diet and 
activities, we did not measure protein catabolic rate and 
Kt/v to assess dietary protein intake and dialysis adequa-
cy.
 In conclusion, we find that raising the pH in HD pa-
tients is not associated with a positive effect on protein 
synthesis, catabolic parameters or endocrine derange-
ment.
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